Impact of FDG PET/CT in directing management of well differentiated neuroendocrine tumours with Ki67 <5%

被引：0
|
作者：
Agrawal, A. [1 ]
Choudhary, S. [1 ]
Puranik, A. [1 ]
Rangarajan, V. [1 ]
Shrikhande, S. [1 ]
Bal, M. [1 ]
Choudhary, V. [1 ]
Bhandare, M. [1 ]
Ramaswamy, A. [1 ]
Purandare, N. [1 ]
Shah, S. [1 ]
机构：
[1] Tata Mem Hosp, Mumbai, Maharashtra, India
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0353
引用
收藏
页码：S544 / S544
页数：1
相关论文
共 50 条
  • [1] Impact of FDG PET/CT Scan in Changing Management of Well-Differentiated Neuroendocrine Tumors With Ki67 Index Less Than or Equal to 5%
    Choudhury, Sayak
    Agrawal, Archi
    Rangarajan, Venkatesh
    Puranik, Ameya
    Bal, Munita
    Chaudhari, Vikram
    Bhandare, Manish
    Purandare, Nilendu
    Shah, Sneha
    Ramaswamy, Anant
    Ostwal, Vikas
    Shrikhande, Shailesh, V
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (11) : E676 - E681
  • [2] Performance of FDG-PET, SRS and CT for diagnosis of well differentiated endocrine carcinomas with high Ki67 (≥10%).
    Abgral, R.
    Leboulleux, S.
    Deandreis, D.
    Auperin, A.
    Dromain, C.
    Duvillard, P.
    Lumbroso, J.
    Schlumberger, M.
    Ducreux, M.
    Baudin, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S273 - S273
  • [3] Diagnosis of well differentiated endocrine carcinomas (WDEC) with elevated Ki67 expression (≥10%): FDG-PET or SRS?
    Abgral, Ronan
    Abgral, Ronan
    Duvillard, Pierre
    Auperin, Anne
    Deandreis, Desiree
    Dromain, Clarisse
    Lumbroso, Jean
    Schlumberger, Martin
    Baudin, Eric
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [4] The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age
    Partelli, Stefano
    Muffatti, Francesca
    Rancoita, Paola Maria Vittoria
    Andreasi, Valentina
    Balzano, Gianpaolo
    Crippa, Stefano
    Doglioni, Claudio
    Rubini, Corrado
    Zamboni, Giuseppe
    Falconi, Massimo
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (05) : 735 - 740
  • [5] Ki-67 index of 5% could better predict the clinical prognosis of well-differentiated pancreatic neuroendocrine tumours
    Yuan, Bing
    Shi, Yanfen
    Li, Yuanliang
    Tan, Haidong
    Jiao, Peipei
    Su, Wenting
    Liu, Meng
    Qi, Zhirong
    Tan, Huangying
    Luo, Jie
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (12) : 1708 - 1714
  • [6] Correlation between metabolic tumor burden at [18F]FDG-PET/CT and Ki67 index in neuroendocrine tumors
    Massri, K.
    Duce, V.
    Margotti, S.
    Volterrani, D.
    Boni, R.
    Grosso, M.
    Mariani, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S377 - S377
  • [7] [18F]FDG-PET/CT Heterogeneity in Patients with Metastatic, Well-Differentiated Pancreatic Neuroendocrine Tumours
    Ortolani, S.
    Cingarlini, S.
    Citton, E.
    Crosara, S.
    De Robertis, R.
    Grego, E.
    Vallerio, P.
    D'Onofrio, M.
    Butturini, G.
    Landoni, L.
    Capelli, P.
    Zuffante, M.
    Ferdeghini, M.
    Salgarello, M.
    Tortora, G.
    NEUROENDOCRINOLOGY, 2016, 103 : 61 - 61
  • [8] Well Differentiated Pancreatic Neuroendocrine Tumors (WDPNET) G3: Does the Ki67 Really Do It All?
    Cros, J.
    Soukeur, M.
    Raffenne, J.
    Florent, D.
    De Montpreville, Thomas V.
    Antoine, M.
    Scoazec, J. Y.
    Cazes, A.
    Svrcek, M.
    Hentic, O.
    Sauvanet, A.
    Bedossa, P.
    Paradis, V.
    Ruszniewski, P.
    Couvelard, A.
    NEUROENDOCRINOLOGY, 2016, 103 : 6 - 6
  • [9] Durable disease control with sunitinib and everolimus in well differentiated neuroendocrine tumors of the pancreas with a high ki67 index.
    Geboes, Karen Paula
    Laurent, Stephanie
    Verroken, Charlotte
    Cesrneli, Ercan
    Lambert, Bieke
    Smeets, Peter
    Vanlander, Aude
    Berrevoet, Frederik
    Libbrecht, Louis
    Ferdinande, Liesbeth
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Clinical usefulness of FDG-PET for management of well-differentiated digestive neuroendocrine tumors
    Perrier, Marine
    Hentic, Olivia
    Walter, Thomas
    Cao, Christine Do
    Cadiot, Guillaume
    de Mestier, Louis
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (12) : 1521 - 1524
12345